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The colorectal carcinoma represents one of the most common and aggressive malignancies, still characterized by an unacceptable
mortality rate, mainly due to the high metastatic potential and to a late diagnosis. In the last years, the research community
focused on the chance of improving the endoscopic screening to detect neoplastic lesions in a very early stage. Several studies
proposed aberrant colonic crypt foci as the earliest recognizable step of transformation in colonic multiphase carcinogenesis.
We previously demonstrated the clinical applicability and predictive power of probe-based confocal laser endoscopy (pCLE) in
superﬁcial colorectal neoplastic lesions and also characterized in vivo a case of dysplasia-associated lesional mass (DALM) in
ulcerative colitis. Now, we aim to evaluate the accuracy of pCLE in the detection of ACF comparing in double-blind manner the
microendoscopic and histopathological features resulting from colonic biopsy. By pCLE, we identiﬁed speciﬁc crypt architecture
modiﬁcations associated with changes in cellular inﬁltration and vessels architecture, highlighting a good correspondence between
pCLE features and histology.
1.Introduction
Colorectal cancer represents the third most common human
malignancy after prostate and lung cancer in males and the
second one after breast carcinoma in females, with more
than 1.200.000 new cases [1, 2], constituting a major cause
of cancer death worldwide, particularly in Europe where
it is responsible for more than 200.000 deaths per year
[3]. Although this unacceptable mortality rate is closely
associated with high metastatic ability of colorectal cancer,
many of the deaths are caused by a late diagnosis. In fact,
the prognosis of each malignancy strongly depends on stage
at diagnosis and most cancers can be successfully treated
if diagnosed at an early stage. For this reason, the research
community focused its eﬀorts not only in attempt to better
understand the molecular mechanisms underlying the colon
carcinogenesis but also on the possibility to improve the
endoscopic screening of the colorectal lesions in the very
early stage. To date, colon endoscopy remains the best way
to make cancer prevention of this district possible. Given2 Gastroenterology Research and Practice
the ﬁnding that conventional colonoscopy sometimes is not
able to diﬀerentiate between neoplastic and nonneoplastic
lesions, several studies evaluated the role of advanced new
endoscopic imaging techniques, such as chromoendoscopy
and confocal laser endomicroscopy (CLE), in the detection
of colorectal lesions [4–6]. CLE enables to obtain in vivo
microscopic images during endoscopy, allowing to make
real-time adequate diagnosis and to perform target biopsies
improving the diagnostic accuracy. Presently, there are two
devices to perform CLE: the endoscope-based confocal
laser endomicroscopy (eCLE; Pentax, Tokio, Japan), in
which a confocal probe is incorporated in the tip of a
routinary endoscope, and the probe-based confocal laser
endomicroscopy(pCLE),inwhichthestand-aloneprobecan
be passed through the biopsy channel of traditional endo-
scope (Cellvizio, Mauna Kea Technologies, Paris, France)
[4, 5, 7] .T od a t et h e r ea r en o ts t i l la d e q u a t ed a t at o
consider an endoscopic technique better than the other
one.
It is known that colorectal carcinogenesis is a multistep
process progressing through several morphological stages
[8]. The earliest phase may be the formation of aberrant
crypt foci (ACF). In fact, the ACF prevalence and density are
greater in patients with colorectal carcinoma and adenoma,
compared to normal controls, and, therefore, these lesions
could be used as biomarker of colorectal cancer [9, 10].
Moreover, considering that ACF are preventable preneoplas-
tic lesions and that their growth is modiﬁed by speciﬁc
modulators, their early detection is very important [11].
However, there is still a wide variation of endoscopic criteria
useful to identify and deﬁne ACF. The main considered
featureisthemucosacolor[12–15],usuallydarkercompared
to the adjacent normal colonic mucosa, but also the crypt
architecture, the crypt lumen size [13, 14, 16], the raised
appearance [13, 15, 16], and the thickness of epithelial lining
[14] are considered. A height of less than 2mm has been
proposed to diﬀerentiate them from colonic polyps in some
recent studies [17].
In a previous study, conducted as conclusion of MIUR/
PRIN project (2007) on this speciﬁc topic, we demonstrated
that pCLE constitutes a reliable tool for the identiﬁcation
of colorectal superﬁcial carcinoma [4]. In addition, we ﬁrst
discussed the pCLE ﬁndings regarding a case of dysplasia-
associated lesional mass (DALM) in chronic ulcerative colitis
(CUC) [5]. On the basis of these previous reports, we
correlate for the ﬁrst time endoscopic and histological
features of ACF in the attempt to validate the promising
role of pCLE as useful and predictive tool of evaluation of
colorectal preneoplastic lesions.
2.MaterialsandMethods
2.1. Patients. A small group constituted of 9 patients with
evidence of ACF at routine colonoscopy were enrolled for
this study. Endoscopic features considered for the identiﬁ-
cation of ACF, according to the literature data, were darker
colonic mucosa after dying, the two-threefold crypt lumen
size, raised appearance, and/or thickened epithelium [12–
14, 16, 18]. Exclusion criteria were patients aged less than 18
years, known allergic diseases, and impaired renal function.
In addition, 5 patients with colonic adenomas and 5 patients
with adenocarcinoma at endoscopy were selected. Three
hyperplastic polyps were added as control.
2.2. Equipment. Lesions were identiﬁed using white-light
endoscopy and NBI followed by pCLE imaging recorded by
a Coloﬂex UHD-type probe, using the Cellvizio Endomi-
croscopy System (Mauna Kea Technologies, Paris, France)
[5]. Coloﬂex UHD-type probe is a 2.5mm catheter probe
inserted through the endoscope-working channel to obtain
dynamic images of the mucosa. pCLE imaging data were
registered at a scan rate of 12 frames per second with a
scanning ﬁeld of 30,000 pixels. The ﬁeld of view is of 240
× 200µm, with a lateral resolution of 1µm. From single
video frames is reconstructed 1 larger static image (4 ×
2mm) by a special computer software (mosaicing), which
uses a hierarchical framework algorithm able to recover
a globally consistent alignment of the input frames, to
compensate for motion-induced distortions and to capture
nonrigid deformations. The resulting image combines all
moving images, cancels motion artifacts, and reconstitutes
panoramas of the tissues.
2.3. Procedure. All examinations were performed by a sin-
gle experienced endoscopist (GDDP). During twenty-four
hours before the procedure, 4L of isotonic polyethylene
glycol solution was administered as a bowel cleansing.
A conscious sedation with midazolam (5–10mg i.v.) was
administered when requested by the patient. After the
identiﬁcation of each lesion on white-light endoscopy or
NBI, a 10–20mg intravenous bolus of Buscopan (hyoscine-
N-butyl-bromide) was given to limit peristaltic artifacts,
followed by the administration of 10mL of 10% sodium
ﬂuorescein for CLE image acquisition. Confocal images
of circumscribed lesions and four segmental “normal”
colorectal quadrants were acquired, the latter used to deﬁne
normality. Specimens obtained (resected lesions and/or
target biopsy) were formalin ﬁxed and paraﬃne m b e d d e d
and, then, stained with hematoxylin-eosin. The histologic
evaluation was performed by two experienced pathologists
(MM and SS) in a blinded fashion and graded in accordance
with the Vienna modiﬁed classiﬁcation of gastrointestinal
epithelial neoplasia [19]. Histologically, ACF were deﬁned
as enlarged crypts (at least 1.5 times larger than normal),
covered by thickened epithelium with lack of stratiﬁcation,
but characterized by regular nuclei with only mild or focal
crowding, often elevated from adjacent normal mucosa,
according to the proposed criteria [20–22].
2.4. Main Outcome Measurements. According to the Paris
Workshop guidelines [23], all identiﬁed lesions were classi-
ﬁed as follows: protruding lesions (Ip: pedunculated polyp;
Ips: subpedunculated polyp; Is: sessile polyp); ﬂat elevated
lesions (0-IIa: ﬂat elevation of mucosa; 0-IIa/c: ﬂat elevation
with central depression); ﬂat lesions (0-IIb: ﬂat mucosalGastroenterology Research and Practice 3
change; 0-IIc: mucosal depression; 0-IIc/IIa: mucosal depres-
sion with raised edge). The diagnostic endoscopic criteria
used for diagnosing ACF were crypts larger in diameter
than the surrounding normal crypts, from which they are
distinguished by deeper color when stained with methylene
blue, thicker epithelium and raised appearance [9, 12–
14, 16, 24–27]. The endoscopy operator (GDDP) made
a preliminary diagnosis based upon the in vivo images
(video sequences) and the mosaic images, according to the
Miami confocal endomicroscopy criteria for the prediction
of intraepithelial colorectal neoplasia [28]. pCLE diagnosis
was then compared with the histopathological diagnosis.
Every image was judged as good, average, or poor by the
principal investigator, basing on presence/absence of moving
artifacts and on a well/poor recognizable crypt and vascular
architecture. To assess interobserver agreement, 50 confocal
video images and mosaicing images of good or average
quality (25 images of neoplastic lesions and 25 images of
nonneoplastic lesions or normal colorectal epithelium) were
randomly selected and evaluated in a blinded fashion by one
endoscopist(DE)withminimalexperiencewithpCLE.Their
prediction of malignant or benign features on pCLE was
compared with the histopathologic diagnosis.
3. Results
For this study, 9 patients (4 males, mean age 65 years, range
56–83) with endoscopic evidence of ACF, 5 patients with
colonic adenoma (5 males, mean age 60,6, range 49–72), 5
patients with colonic carcinoma (3 males, mean age 63,2,
range 56–73) and 3 patients with hyperplastic polyps (2
males, mean age 57,7, range 41–76) were considered. A total
of 30 lesions were identiﬁed. A single lesion was found in 14
(63,6%) cases, and 8 (36,4%) patients had two lesions. The
lesions were located in the rectum in 5 cases, in the sigmoid
colon in 4 cases, in the descending colon in 5 cases, and in
the right colon in 8 cases.
3.1. Correlation of Histopathology and pCLE Images. On
pCLE examination, normal mucosa was deﬁned by a hexag-
onal, honeycomb appearance with a round crypt structure,
surrounded by regular vessels, covered by a homogeneous
epithelium with “black-hole” goblet cells in the subcellular
matrix; hyperplastic mucosa was characterized by crypts
with slit or stellate openings covered by uniform epithelium,
with a regular vessel architecture, with some increase in
pericryptic capillary density; neoplastic tissue was repre-
sented by “dark” cells, with mucin and goblet cell/crypt
density depletion; the architectural pattern was irregular, as
well as the epithelial thickness, with villiform structures or
cryptfusionanddistortion,and“dark”epithelialborder.The
blood vessels were dilated and irregularly branching.
A suspected ACF, identiﬁed with traditional endoscopy,
can show characteristics of dysplastic adenoma or hyperplas-
tic polyp on pCLE, as previously described.
All pCLE images diagnosed as “normal” mucosa showed
normal architecture at histopathologic evaluation. Among
cases recorded as ACF at pCLE, histologic evaluation con-
ﬁrmed the presence of aberrant crypts in 7 biopsy specimens
and in two of these cases a diagnosis of microadenoma
with low-grade displasia was made (Figure 1). Four out of
5 lesions diagnosed as adenoma and 5/5 diagnosed as adeno-
carcinomaatpCLEshowedcorrespondenceathistology.One
lesiondiagnosedasadenomaonCLEathistologicevaluation
was diagnosed as hyperplastic polyp. Hyperplastic polyps
used as control and so selected on confocal imaging were
conﬁrmed as benign on histology, but in 2 of these features
of hyperplasia were showed. No patients showed endoscopic
complications or adverse reactions to sodium ﬂuorescein;
onlyaslightyellowishdiscolorationoftheskinwasrecorded,
which usually disappeared within 30–60min.
4. Discussion
Although to date there is not still a close correspondence
between the conventional endoscopic images and histo-
logical assessment, this association of tools remains the
best way to diagnose accurately and then treat as early as
possible many diseases of diﬀerent district, especially of the
colorectal tract, including chronic inﬂammatory, preneo-
plastic, and neoplastic diseases. Basing upon the ﬁnding that
conventional colonoscopy is not always able to diﬀerentiate
between neoplastic and nonneoplastic lesions, in recent
years,severalstudieshighlightedthepotentialuseofconfocal
laser endomicroscopy (CLE), a new emerging technique, in
the screening patients for early colorectal cancer detection
and prevention [4–6, 29, 30]. This technique allows to obtain
in vivo microscopic images during endoscopy, enabling to
make real-time diagnosis, and to perform targeted biopsies
improving the diagnostic accuracy. These newly developed
technologyies have been evaluated for several diseases of
diﬀerent districts, such as lung and bladder [31, 32], and
in particular it was suggested that pCLE can be employed
in the detection of several gastrointestinal tract diseases. In
fact, Wang et al. (2011) in his recent work concludes that
pCLE can assess the severity of Helicobacter pylori gastritis
[33], Meining et al. support that pCLE can be used in the
management of indeterminate pancreaticobiliary structures
[34], and Gaddam developed six diagnostic criteria to
identify dysplasia in Barrett’s esophagus [35]. However, there
are conﬂicting advises about the CLE promising utility:
in fact, Bisschops in an editorial entitled “Confocal laser
endomicroscopy: ﬁnally ready to change clinical practice?”
agreed that the CLE is an innovative imaging tool but not
enough to justify its use in a general endoscopy unit [36].
Therefore, advantages and limitations of this novel imaging
tool, in particular of the pCLE, need to be acknowledged.
ACF, ﬁrst reported by Bird [37], are considered the
result of ﬁrst insult in CRC and [8], therefore, represent
the putative earliest known morphological precursors to
colorectal adenoma, capable of progression to CRC, and a
marker of colorectal cancer risk [38–41]. However, there
are still conﬂicting data about ACF meaning: some authors
consider ACF as detectable ﬁrst step of colon carcinogenesis;
others do not recognize this role. They are localized colonic4 Gastroenterology Research and Practice
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Figure 1: (a) Conventional “white-light” endoscopy of an ACF; (b), (d), and (f) pCLE of the lesion showing an enlarged crypt (red
arrow, (b)) and normal globet cell density; (c), (e), and (g) hystologic features of the lesion, showing some enlarged crypts, with thickened
epithelium with partial lack of stratiﬁcation, in the presence of mild dysplasia.
mucosal alterations involving crypts and their surface is
epithelium. Histologically, ACF are not speciﬁc entity, but
morphologically and genetically heterogeneous lesions.
ACF can be identiﬁed by high-magniﬁcation chromoen-
doscopy(MCE),butthereisstillvariabilityintheendoscopic
criteria used to deﬁne these lesions. The morphologic
features most commonly used are darker staining [12–14,
18], larger crypt size [13, 14], raised appearance [13, 16,
18], thicker epithelial lining [14], and dilated crypt lumen
[16], compared to the surrounding normal mucosa. In
the diﬀerent studies concerning ACF, a great variability in
prevalence [12, 13] and correspondence to histology was
found [14, 16]. In fact, data obtained in works using MCE
[42] show a prevalence of ACF ranging from 15% [12]t o
100% [13] in patients with a normal colon on colonoscopy
and from 0% [12] to 61% [16] in patients with sporadic
colorectal carcinoma, while the rate of agreement between
the endoscopic identiﬁcation of ACF and histological conﬁr-
mation ranges from 53% [16] to 92% [14]. This may reﬂect
the actual diﬃculty in identifying accurately small lesions
needed to be biopsied and, more importantly, the necessity
to deﬁne the endoscopic criteria of ACF [43].
Therefore, in this study we evaluated the correspondence
between endoscopic identiﬁcation by pCLE and histological
diagnosis of a small series of ACF, to validate the promising
role of pCLE as useful tool in the evaluation of colorectal
preneoplasticlesions,inparticularACF.Inourwork,7outof
9 cases (78%) diagnosed as ACF on conventional endoscopy
and conﬁrmed on pCLE showed corresponding histological
features.
Basing upon our results, we consider a real advantage
of the potential of obtaining microscopic images in real
time using pCLE because it allows an accurate endoscopic
diagnosis and a contemporaneous possibility of treatment,
with corresponding time savings and reduced costs of
the procedure. Moreover, the “in vivo diagnosis”c o u l d
signiﬁcantly reduce the number of biopsies to be performed,
restricting to those lesions with a real malignant potential,
for example, in the management of several chronic diseases,
and so limiting the adverse reactions that could occur during
multiple randomized biopsy [30]. pCLe major disadvantages
are operator dependency regarding the diﬃculty in main-
taining the stability of the probe and in the interpretation of
morphologic features and the limited depth of penetration
of the tool [6]. This study was designed on the basis of
results obtained in twoprevious works, in which we reported
our experience in the identiﬁcation of superﬁcial colonic
neoplasia and in DALM associated with CUC [4, 5]. In fact,
we ﬁrst demonstrated that pCLE has a predictive value of in
vivo identiﬁcation of colorectal preneoplastic and neoplasticGastroenterology Research and Practice 5
lesions [4]. In the second one, instead, we showed the
switch from the inﬂamed to neoplastic mucosa in a patient
with chronic ulcerative colitis (CUC) [5]. We conﬁrmed
previously reported data, according to Kuiper’s work [44], in
which they also proposed a new pCLE colon classiﬁcation,
highlighting the high level of accuracy of pCLE in iden-
tifying colonic intraepithelial neoplasia. Furthermore, we
demonstrated the clinical applicability and predictive power
of pCLE also in a group of aberrant colonic crypt foci (ACF)
collected during laser confocal endomicroscopy, through the
concordance between endoscopic and histological features
(rate of architectural alterations in the absence or presence
of epithelial dysplasia).
5. Conclusion
To the best of our knowledge, this work constitutes the
ﬁrst attempt to correlate the identiﬁcation of ACF by pCLE
with the actual putative advantages, both in terms of ﬁnal
diagnosis and the concern of the compliance of patients for
the endoscopy procedure. Although this study considered
only a limited number of patients, the results obtained
allow us to suppose that this endoscopic image technique
is extremely useful in the identiﬁcation of these putative
very early colonic preneoplastic lesions. This leads to several
considerations: the introduction of this imaging technique
in an endoscopy unit allows to save time, decreasing both
the risk for patients during colonoscopy and the procedure’s
costs. These data will be validated in future studies on a
signiﬁcantly larger study population. However, these prelim-
inary ﬁndings support the idea that pCLE may signiﬁcantly
improve our chances to morphologically speciﬁcally detect
the colon areas corresponding to ACF, thus increasing the
diagnostic accuracy.
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